INVITROCUE

In News

Singapore approves Invitrocue's Onco-PDO test as personalised oncology service - BioSpectrum Asia

BioSpectrum Asia - Mar 05, 2024

3 companies fined nearly $1.2m in total for financial reporting breaches - Accounting Times

Accounting Times - Apr 01, 2026

Singapore entrepreneur sold family home twice to fund startups, and gave up S$750,000 annual salary - Yahoo Finance Singapore

Yahoo Finance Singapore - Feb 27, 2024

GOLLOG is the official partner of Invitrocue Brasil and Care On Logística in the transport of cancer tests throughout the country - Aeroflap

Aeroflap - Jun 30, 2023

International MoU between Hong Kong, Singapore, and Europe Biomedical Talents | HKSTP - Hong Kong Science & Technology Parks Corporation

Hong Kong Science & Technology Parks Corporation - May 17, 2022

A*STAR’s R&D gives Singaporean biomedical firm a headstart - Agency for Science, Technology and Research

Agency for Science, Technology and Research - Jun 21, 2018

Biotech firm offers personalized cancer drug test to Hong Kong - The Standard (HK)

The Standard (HK) - Jun 28, 2021

New joint innovation laboratory launched for advanced cancer treatment - BioSpectrum Asia

BioSpectrum Asia - Jul 25, 2017

Me & My Money: Entrepreneur sells his home to fund biotech start-up - The Straits Times

The Straits Times - Apr 21, 2024

Three Firms Fined $1M+ for Reporting Breaches - Mirage News

Mirage News - Apr 01, 2026

Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.

AI Sentiment